Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-associated retinopathy--a case report.

I Mantel1, L Konstantinidis, L Zografos

  • 1University Eye Clinic, Jules Gonin Hospital, Lausanne, Switzerland. irmela.mantel@ophtal.vd.ch

Klinische Monatsblatter Fur Augenheilkunde
|April 27, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term outcomes of the observe-and-plan regimen in treating neovascular age-related macular degeneration: a retrospective real-life analysis.

Eye (London, England)·2025
Same author

Non-immediate drug hypersensitivity reactions secondary to intravitreal anti-vascular endothelial growth factors.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2021
Same author

Characteristics of patients with complete visual acuity recovery after vitrectomy for macula-off retinal detachment.

Eye (London, England)·2020
Same author

Orbital exenteration and conjunctival melanoma: a 14-year study at the Jules Gonin Eye Hospital.

Eye (London, England)·2020
Same author

Patellar tendinopathy in young elite soccer- clinical and sonographical analysis of a German elite soccer academy.

BMC musculoskeletal disorders·2017
Same author

Analysis of the biliostatic potential of two sealants in a standardized porcine model of liver resection.

American journal of surgery·2017

Interferon-associated retinopathy can present atypically, featuring microaneurysms and pigment changes. Early detection and careful monitoring are crucial for managing this condition and preventing vision loss.

Area of Science:

  • Ophthalmology
  • Hepatology
  • Pharmacology

Background:

  • Interferon alpha (IFN-α) is a therapeutic agent used in oncology and for treating chronic hepatitis C.
  • Interferon-associated retinopathy (IAR) is a known complication, typically presenting with cotton wool spots, hemorrhages, and edema.
  • While uncomplicated IAR is usually reversible, severe forms involving vascular occlusion can lead to irreversible vision loss.

Observation:

  • A 63-year-old patient receiving Interferon alfa 2a for hepatitis C developed an atypical retinopathy.
  • Fundus examination revealed flame-shaped hemorrhages, cotton wool spots, microaneurysms, and pigment epithelial abnormalities.
  • The patient had co-existing arterial hypertension, anemia, and glucose intolerance, potentially influencing the atypical presentation.

Findings:

Related Experiment Videos

  • The patient was monitored closely with continued, reduced-dose interferon therapy.
  • No vision-threatening complications were observed during the follow-up period.
  • The atypical features included microaneurysms, Roth spots, and retinal pigment changes.

Implications:

  • Interferon-associated retinopathy can manifest with unusual clinical features beyond typical presentations.
  • Prompt diagnosis and vigilant follow-up are essential to prevent progression to irreversible visual impairment.
  • Consideration of dose reduction or discontinuation of interferon therapy is warranted in managing IAR.